title: New England Compounding Center Indictment.
abstract: This article is a review of the lapses in compliance with United States Pharmacopeia standards and pharmacy law as alleged by the New England Compounding Center indictment. This indictment was a result of an outbreak of fungal meningitis traced to fungal contamination of compounded methylprednisolone suspension for epidural steroid injections. This article is also intended as a gap analysis for compounders to review compliance at their own facility, and, if necessary, take the appropriate steps to implement best practices.
authors.forename: Joe
authors.initials: J
authors.lastname: Cabaleiro
mesh_terms: D004339:Drug Compounding / Q000592:standards; D004784:Environmental Monitoring; D007880:Legislation, Drug; D010602:Pharmacopoeias as Topic; D013242:Sterilization; D014481:United States